‘Very Low’ Dose Moderna COVID-19 Vaccine Elicits Immune Response with No Side Effect, First Human Trial Show May 20, 2020 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · https://www.sciencetimes.com/articles/25721/20200518/very-low-dose-moderna-covid-19-vaccine-elicits-immune-response.htm Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintMorePocketLike this:Like Loading... Related
